Latest News & Updates
Breaking News
23 hours ago
Vaibhavi M.
Other trending news you may like to read
Roche Gains FDA Priority Review for Colon Cancer Drug with October 2026 Decision Date
FDA grants Roche Priority Review for a colon cancer drug, setting a 9 October 2026 decision date after trial data showed 50% recurrence reduction.
Vaibhavi M.
AbbVie Acquires Apogee Biologics in $10.9 Billion Deal to Extend Immunology Pipeline
AbbVie acquires Apogee for $10.9B, raising immediate tech transfer and GMP integration questions for biologics manufacturing teams.
Vaibhavi M.
Wesley Pharmaceuticals Launches Three Injectable Formulations Expanding Its 503(b) Outsourcing Portfolio
Wesley Pharmaceuticals launches three 503(b)-compliant multi-dose injectables, expanding outsourcing supply options for health networks.
Vaibhavi M.
Allergan Aesthetics Gains Health Canada Approval for Boey® as First Botulinum Serotype E Neurotoxin
Health Canada approves Boey® (trenibotulinumtoxinE), the world's first botulinum serotype E aesthetic neurotoxin, setting a new biologics regulatory precedent.
Vaibhavi M.
